Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1520-1528

  Zheng, Yonglan ^a   Ogundiran, Temidayo O ^b   Falusi, Adeyinka G ^b   Nathanson, Katherine L ^c   John, Esther M ^d,e   Hennis, Anselm J M ^f,g   Ambs, Stefan ^h   Domchek, Susan M ^c   Rebbeck, Timothy R ^c   Simon, Michael S ⁱ   Nemesure, Barbara ^g   Wu, Suh Yuh ^g   Leske, Maria Cristina ^g   Odetunde, Abayomi ^b   Niu, Qun ^a   Zhang, Jing ^a   Afolabi, Chibuzor ^b   Gamazon, Eric R ^a   Cox, Nancy J ^a   Olopade, Christopher O ^a   Olopade, Olufunmilayo I ^a   Huo, Dezheng ^a   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^e STANFORD CANCER INSTITUTE   (United States)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

^g STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HCN 1 PROTEIN; MRPS 30 PROTEIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 6; CONFIDENCE INTERVALS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880281989     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt090     Document Type: Article

References (51)

1. Foulkes, W.D. (2008) Inherited susceptibility to common cancers. N. Engl. J. Med., 359, 2143-2153.
2. Easton, D.F. et al.; SEARCH collaborators; kConFab; AOCS Management Group. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1093.
3. Hunter, D.J. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
4. Stacey, S.N. et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39, 865-869.
5. Gold, B. et al. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc. Natl. Acad. Sci. U.S.A., 105, 4340-4345.
6. Stacey, S.N. et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 40, 703-706.
7. Zheng, W. et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet., 41, 324-328.
8. Ahmed, S. et al.; SEARCH; GENICA Consortium; kConFab; Australian Ovarian Cancer Study Group. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet., 41, 585-590.
9. Thomas, G. et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584.
10. Turnbull, C. et al.; Breast Cancer Susceptibility Collaboration (UK). (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet., 42, 504-507.
11. Antoniou, A.C. et al.; EMBRACE; GEMO Study Collaborators; HEBON; kConFab; SWE-BRCA; MOD SQUAD; GENICA. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet., 42, 885-892
12. Gaudet, M.M. et al.; HEBON Study Collaborators; OCGN; kConFab; EMBRACE. (2010) Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet., 6, e1001183.
13. Li, J. et al. (2010) A genome-wide association scan on estrogen receptornegative breast cancer. Breast Cancer Res., 12, R93.
14. Fletcher, O. et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J. Natl. Cancer Inst., 103, 425-435.
15. Lindström, S. et al. (2011) Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat. Genet., 43, 185-187.
16. Sehrawat, B. et al. (2011) Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum. Genet., 130, 529-537.
17. Fejerman, L. et al. (2012) Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum. Mol. Genet., 21,1907-1917.
18. Kim, H.C. et al. (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res., 14, R56.
19. Chen, F. et al. (2013) A genome-wide association study of breast cancer in women of African ancestry. Hum. Genet., 132, 39-48.
20. Haiman, C.A. et al.; Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium. (2011) A common variant at the TERTCLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet., 43, 1210-1214.
21. Cai, Q. et al. (2011) Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum. Mol. Genet., 20, 4991-4999.
22. Long, J. et al. (2012) Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet., 8, e1002532.
23. Siddiq, A. et al.; Australian Breast Cancer Tissue Bank Investigators; Familial Breast Cancer Study; GENICA Consortium. (2012) A metaanalysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet., 21, 5373-5384.
24. Rebbeck, T.R. et al. (2009) Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis, 30, 269-274.
25. Zheng, W. et al. (2009) Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol. Biomarkers Prev., 18, 2761-2764.
26. Barnholtz-Sloan, J.S. et al. (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis, 31, 1417-1423.
27. Chen, F. et al. (2011) Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations. Eur. J. Hum. Genet., 19, 243-245.
28. Cai, Q. et al. (2011) Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res., 71, 1344-1355.
29. Hutter, C.M. et al. (2011) Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiol. Biomarkers Prev., 20, 1950-1959.
30. Huo, D. et al. (2012) Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis, 33, 835-840.
31. Ruiz-Narváez, E.A. et al. (2013) Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women. Carcinogenesis, 34, 287-291.
32. Udler, M.S. et al.; SEARCH Collaborators. (2009) FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum. Mol. Genet., 18, 1692-1703.
33. Udler, M.S. et al. (2010) Fine scale mapping of the breast cancer 16q12 locus. Hum. Mol. Genet., 19, 2507-2515.
34. Ruiz-Narváez, E.A. et al. (2010) Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol. Biomarkers Prev., 19, 1320-1327.
35. Stacey, S.N. et al. (2010) Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet., 6, e1001029.
36. Chen, F. et al. (2011) Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum. Mol. Genet., 20, 4491-4503.
37. Zheng, Y. et al. (2012) Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Res. Treat., 132, 341-345.
38. Hou, N. et al. (2012) Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiol. Biomarkers Prev., 21, 552-556.
39. Nemesure, B. et al.; Barbados National Cancer Study Group. (2009) Risk factors for breast cancer in a black population-the Barbados National Cancer Study. Int. J. Cancer, 124, 174-179.
40. John, E.M. et al. (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA, 298, 2869-2876.
41. Boersma, B.J. et al. (2006) Association of breast cancer outcome with status of p53 and MDM2 SNP309. J. Natl. Cancer Inst., 98, 911-919.
42. Huo, D. et al. (2008) Parity and breastfeeding are protective against breast cancer in Nigerian women. Br. J. Cancer, 98, 992-996.
43. Ruiz-Narváez, E.A. et al. (2011) Validation of a small set of ancestral informative markers for control of population admixture in African Americans. Am. J. Epidemiol., 173, 587-592.
44. Chanock, S.J. et al. (2007) Replicating genotype-phenotype associations. Nature, 447, 655-660.
45. Li, J. et al. (2011) A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res. Treat., 126, 717-727.
46. Kan, Z. et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature, 466, 869-873.
47. Ellis, M.J. et al. (2012) Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature, 486, 353-360.
48. Shah, S.P. et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486, 395-399.
49. Stephens, P.J. et al.; Oslo Breast Cancer Consortium (OSBREAC). (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature, 486, 400-404.
50. Banerji, S. et al. (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature, 486, 405-409.
51. Lin, P.I. et al. (2007) No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet., 80, 531-538.